CNS Pharmaceuticals (CNSP) said Wednesday it will implement a 1-for-50 reverse stock split to raise the company's per-share trading price and ensure compliance with Nasdaq's minimum share price listing requirement.
The company said its common stock will start trading on a split-adjusted basis on Nasdaq on Friday.
Shares of CNS Pharmaceuticals fell over 33% in recent trading.
Price: 0.10, Change: -0.05, Percent Change: -33.33
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。